Top Markets
#1 Black Phoenix Black Phoenix +21,406.19%
#2 Nesa Nesa +679.66%
#3 Cortex Cortex +92.45%
#4 Ontology Gas Ontology Gas +59.74%
#5 Kinesis Silver Kinesis Silver +54.91%
#6 Biconomy Biconomy +26.93%
#7 Magma Finance Magma Finance +25.67%
#8 QuantixAI QuantixAI +23.07%
#9 EXOD EXOD +22.78%
#10 SAFEcoin SAFEcoin +20.40%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Rank in Stocks #18871
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Share Price
$2.51
Market Cap
$183.34M
Change (1 day)
0.90%
Change (1 year)
91.17%
Country
TW
Trade Steminent Biotherapeutics Inc. (7729)

Category

Healthcare
Dividend history for Steminent Biotherapeutics Inc. (7729)
Steminent Biotherapeutics Inc. (stock symbol: 7729) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Steminent Biotherapeutics Inc. (7729) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH